Katie Moynihan, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 14 | 2024 | 1354 | 4.830 |
Why?
|
Intensive Care Units, Pediatric | 12 | 2023 | 981 | 3.260 |
Why?
|
Terminal Care | 7 | 2023 | 1694 | 2.280 |
Why?
|
Virus Diseases | 3 | 2020 | 711 | 1.280 |
Why?
|
Heart Diseases | 4 | 2022 | 2788 | 0.990 |
Why?
|
Respiratory Insufficiency | 2 | 2023 | 1199 | 0.980 |
Why?
|
Ethics Consultation | 1 | 2024 | 52 | 0.910 |
Why?
|
Hospitalization | 5 | 2023 | 10262 | 0.850 |
Why?
|
Partial Thromboplastin Time | 2 | 2021 | 206 | 0.810 |
Why?
|
Prothrombin Time | 1 | 2021 | 119 | 0.800 |
Why?
|
Critical Care | 8 | 2023 | 2647 | 0.770 |
Why?
|
Child | 31 | 2024 | 77709 | 0.750 |
Why?
|
Respiratory Tract Infections | 2 | 2019 | 961 | 0.730 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 165 | 0.730 |
Why?
|
Thrombelastography | 1 | 2021 | 164 | 0.710 |
Why?
|
Oximetry | 1 | 2023 | 471 | 0.710 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.700 |
Why?
|
Tracheostomy | 1 | 2023 | 401 | 0.700 |
Why?
|
Palliative Care | 6 | 2022 | 3493 | 0.670 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2018 | 50 | 0.650 |
Why?
|
Intubation | 1 | 2019 | 141 | 0.650 |
Why?
|
Referral and Consultation | 3 | 2023 | 3528 | 0.620 |
Why?
|
Decision Making | 2 | 2023 | 3887 | 0.580 |
Why?
|
Heparin | 3 | 2020 | 1637 | 0.570 |
Why?
|
Infant | 16 | 2023 | 35136 | 0.570 |
Why?
|
Blood Coagulation | 2 | 2021 | 1127 | 0.560 |
Why?
|
Viruses | 1 | 2020 | 374 | 0.560 |
Why?
|
Blood Coagulation Tests | 1 | 2017 | 263 | 0.550 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5319 | 0.500 |
Why?
|
Transportation of Patients | 1 | 2016 | 185 | 0.500 |
Why?
|
Myocarditis | 1 | 2021 | 771 | 0.480 |
Why?
|
Heart Defects, Congenital | 3 | 2020 | 4584 | 0.470 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3537 | 0.460 |
Why?
|
Death | 3 | 2023 | 678 | 0.450 |
Why?
|
Hospital Mortality | 4 | 2021 | 5317 | 0.420 |
Why?
|
Cause of Death | 2 | 2021 | 3584 | 0.420 |
Why?
|
Australia | 3 | 2020 | 1170 | 0.410 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.400 |
Why?
|
Family | 1 | 2022 | 3147 | 0.390 |
Why?
|
Infant, Newborn | 11 | 2023 | 25625 | 0.380 |
Why?
|
Thrombosis | 2 | 2022 | 2968 | 0.380 |
Why?
|
Retrospective Studies | 17 | 2024 | 77449 | 0.380 |
Why?
|
Critical Illness | 2 | 2021 | 2670 | 0.370 |
Why?
|
Maternal Welfare | 1 | 2010 | 115 | 0.360 |
Why?
|
Intensive Care Units | 2 | 2023 | 3679 | 0.360 |
Why?
|
Cross Infection | 1 | 2019 | 1416 | 0.350 |
Why?
|
Patient Transfer | 1 | 2016 | 761 | 0.330 |
Why?
|
Length of Stay | 5 | 2024 | 6309 | 0.330 |
Why?
|
Humans | 43 | 2024 | 744343 | 0.320 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3158 | 0.300 |
Why?
|
Health Priorities | 1 | 2010 | 380 | 0.300 |
Why?
|
New Zealand | 2 | 2019 | 355 | 0.290 |
Why?
|
Child Welfare | 1 | 2010 | 523 | 0.280 |
Why?
|
Child, Preschool | 8 | 2021 | 41006 | 0.270 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3229 | 0.250 |
Why?
|
Communication | 3 | 2023 | 3749 | 0.230 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.220 |
Why?
|
Heart Failure | 2 | 2023 | 10900 | 0.210 |
Why?
|
Child Mortality | 2 | 2016 | 198 | 0.200 |
Why?
|
Dissent and Disputes | 1 | 2022 | 141 | 0.190 |
Why?
|
Technology | 1 | 2023 | 305 | 0.190 |
Why?
|
Coronary Care Units | 1 | 2021 | 214 | 0.170 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2569 | 0.170 |
Why?
|
Social Responsibility | 1 | 2022 | 389 | 0.170 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2023 | 341 | 0.170 |
Why?
|
Mycoplasma pneumoniae | 1 | 2018 | 43 | 0.170 |
Why?
|
Hospital Charges | 1 | 2021 | 362 | 0.170 |
Why?
|
Paternalism | 1 | 2018 | 46 | 0.160 |
Why?
|
Hemostatics | 1 | 2020 | 229 | 0.160 |
Why?
|
Acetaminophen | 1 | 2021 | 545 | 0.150 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.150 |
Why?
|
Fetal Diseases | 1 | 2023 | 903 | 0.150 |
Why?
|
Femoral Artery | 1 | 2022 | 845 | 0.150 |
Why?
|
Travel | 1 | 2023 | 788 | 0.140 |
Why?
|
Adolescent | 6 | 2021 | 85781 | 0.140 |
Why?
|
Catheterization | 1 | 2022 | 1470 | 0.140 |
Why?
|
Withholding Treatment | 1 | 2021 | 599 | 0.140 |
Why?
|
Tetralogy of Fallot | 1 | 2020 | 623 | 0.130 |
Why?
|
Community-Acquired Infections | 1 | 2018 | 465 | 0.120 |
Why?
|
Preoperative Period | 1 | 2017 | 549 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2024 | 1775 | 0.120 |
Why?
|
Anesthesia, General | 1 | 2021 | 1171 | 0.120 |
Why?
|
Reference Values | 1 | 2021 | 4982 | 0.120 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2886 | 0.110 |
Why?
|
Male | 10 | 2022 | 350118 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.110 |
Why?
|
Female | 12 | 2023 | 380194 | 0.110 |
Why?
|
Chi-Square Distribution | 1 | 2019 | 3508 | 0.110 |
Why?
|
Birth Weight | 1 | 2020 | 2069 | 0.100 |
Why?
|
Patient Discharge | 2 | 2021 | 3313 | 0.100 |
Why?
|
Anticoagulants | 3 | 2021 | 4599 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1486 | 0.090 |
Why?
|
Health Personnel | 1 | 2023 | 3218 | 0.090 |
Why?
|
Medicaid | 1 | 2023 | 2736 | 0.090 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.080 |
Why?
|
Patient Participation | 1 | 2018 | 1457 | 0.080 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.080 |
Why?
|
Comorbidity | 1 | 2022 | 10388 | 0.080 |
Why?
|
Parents | 1 | 2021 | 3407 | 0.080 |
Why?
|
Maternal Mortality | 1 | 2010 | 310 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1668 | 0.080 |
Why?
|
Developing Countries | 1 | 2020 | 2815 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.080 |
Why?
|
Heart | 1 | 2020 | 4467 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4986 | 0.070 |
Why?
|
Uganda | 1 | 2010 | 1243 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5137 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.070 |
Why?
|
Risk Factors | 4 | 2023 | 72290 | 0.070 |
Why?
|
Models, Biological | 1 | 2021 | 9583 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29063 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3475 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12245 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2023 | 63114 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.040 |
Why?
|
Protamines | 1 | 2019 | 106 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 292 | 0.040 |
Why?
|
Health Policy | 1 | 2010 | 2661 | 0.040 |
Why?
|
Catheters | 1 | 2020 | 425 | 0.040 |
Why?
|
Camptothecin | 1 | 2000 | 576 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1681 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2021 | 1150 | 0.040 |
Why?
|
Device Removal | 1 | 2021 | 656 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 850 | 0.030 |
Why?
|
United States | 1 | 2023 | 69872 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 866 | 0.030 |
Why?
|
India | 1 | 2020 | 2197 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 780 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2044 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 40561 | 0.030 |
Why?
|
Adult | 2 | 2022 | 214055 | 0.020 |
Why?
|
Patient Selection | 1 | 2021 | 4215 | 0.020 |
Why?
|
Sarcoma | 1 | 2000 | 1897 | 0.020 |
Why?
|
Premature Birth | 1 | 2020 | 1721 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
KB Cells | 1 | 2000 | 14 | 0.010 |
Why?
|
Topotecan | 1 | 2000 | 137 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 2000 | 577 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2000 | 13695 | 0.010 |
Why?
|
Liposomes | 1 | 2000 | 759 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2000 | 2327 | 0.010 |
Why?
|
Area Under Curve | 1 | 2000 | 1654 | 0.010 |
Why?
|
Drug Carriers | 1 | 2000 | 693 | 0.010 |
Why?
|
Mice, Nude | 1 | 2000 | 3689 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2000 | 3557 | 0.010 |
Why?
|
Mice | 1 | 2000 | 81183 | 0.000 |
Why?
|
Animals | 1 | 2000 | 168757 | 0.000 |
Why?
|